RH
Rh
RH's fundamentals are mixed, but it looks cheap: trading at 23x earnings, below its usual 31x. Analysts expect strong earnings growth, though they disagree widely on how much.
RH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
RH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
RH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $80.52 | -38% |
| Forward | 17x | $129 | — |
| Current | 23x | $129 | — |
| Fair | 31x | $174 | +35% |
| Expensive | 59x | $332 | +157% |
Historical ranges are pointers, not guarantees.
RH's PE is in its cheap range at 23x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
RH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for RH, with profitability improving. However, they disagree widely on these estimates.
RH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.76 | +38% |
| Q3 2026 | $5.62 | +4.3% |
| Q2 2026 | $5.18 | +23% |
| Q1 2026 | $6.31 | +74% |
| Q4 2025 | $5.56 | +46% |
| Q3 2025 | $5.39 | +164% |
| Q2 2025 | $4.22 | +6.8% |
| Q1 2025 | $3.62 | -39% |
| Q4 2024 | $3.82 | -59% |
RH's earnings per share have fallen from their peak: $5.62 over the past year, against $25.16 in early 2022.
RH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $922.2M | +2.6% |
| Q2 2026 | $800.3M | -1.7% |
| Q1 2026 | $842.6M | +3.7% |
| Q4 2025 | $883.8M | +8.9% |
| Q3 2025 | $899.2M | +8.4% |
| Q2 2025 | $814M | +12% |
| Q4 2024 | $811.7M | +8.1% |
| Q3 2024 | $829.7M | +3.6% |
RH's revenue has held roughly level: $922M last quarter, up 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -2.7 points |
| Q2 2026 | 4.3% | -2.6 points |
| Q1 2026 | 11% | +2.8 points |
| Q4 2025 | 12% | -0.5 points |
| Q3 2025 | 14% | +2.7 points |
| Q2 2025 | 6.9% | -0.6 points |
| Q1 2025 | 8.7% | N/A |
| Q4 2024 | 13% | +5.7 points |
RH's operating margin was 12% last quarter, down 2.7 points from the same quarter a year ago.
RH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $99.6M | +23% |
| Q2 2026 | $13.3M | -61% |
| Q1 2026 | $54.6M | +$124.3M |
| Q4 2025 | $83M | +$179M |
| Q3 2025 | $80.7M | +$118.6M |
| Q2 2025 | $34.1M | +$44.2M |
| Q1 2025 | -$69.7M | +$181.8M |
| Q4 2024 | -$96M | -646% |
RH's free cash flow has turned positive after two years mostly in the red: $251M over the past year.
RH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.4% | +824K shares |
| 1 year | -0.3% | -68K shares |
| 3 years | -13% | -3.1M shares |
| 5 years | -37% | -11.5M shares |
| Available history | -19% | -4.5M shares |
RH has 20M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q1 2024 | — |
| Q4 2023 | $44.6M |
| Q1 2023 | $713.6M |
| Q4 2022 | $31.7M |
| Q1 2020 | — |
| Q4 2019 | — |
RH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.2x | Very low |
RH has more cash than debt.
RH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.3 | Neutral |
| Stochastic | 30.5 | Neutral |
RH's weekly RSI is 44 (neutral) and its Stochastic is 30 (neutral).
RH PE vs Consumer Cyclical Sector
| Metric | RH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 28% above |
| PE % | 32 | 47 | 15 pts below |
RH is trading at 23x earnings, a 28% premium to the Consumer Cyclical sector's median of 18x.
RH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $127.4 | 1.4% above |
| 20 week MA | $148.5 | 13% below |
| 50 week MA | $156.8 | 18% below |
| 100 week MA | $198.9 | 35% below |
| 200 week MA | $243.8 | 47% below |
RH has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 47% below its 200-week average.
RH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $214.9 | $475.7 | +121% |
| 2021 | $475.7 | $546.1 | +15% |
| 2022 | $546.1 | $264.4 | -52% |
| 2023 | $264.4 | $291.5 | +10% |
| 2024 | $291.5 | $398.1 | +37% |
| 2025 | $398.1 | $185.7 | -53% |
| 2026 YTD | $185.7 | $129.2 | -30% |
RH's yearly returns have swung widely, from +121% in 2020 to −53% in 2025. It's down 30% so far in 2026.